ASCO 2022 Conference Coverage


 

Lecture Summary - ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastrointestinal, Liver, Effusion, and Renal Safety Characterization in the BFORE Trial

13 views
June 15, 2022
Comments 0
Login to view comments. Click here to Login